US Bancorp’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.8K Buy
5,587
+1,084
+24% +$13.5K ﹤0.01% 2596
2025
Q4
$51.5K Sell
4,503
-48,148
-91% -$565K ﹤0.01% 2688
2025
Q3
$668K Sell
52,651
-9,176
-15% -$133K ﹤0.01% 1350
2025
Q2
$982K Buy
61,827
+6,604
+12% +$98.8K ﹤0.01% 1116
2025
Q1
$825K Sell
55,223
-4,590
-8% -$81.3K ﹤0.01% 1176
2024
Q4
$1.14M Buy
59,813
+260
+0.4% +$5.5K ﹤0.01% 1072
2024
Q3
$1.61M Buy
59,553
+3,397
+6% +$86.7K ﹤0.01% 937
2024
Q2
$1.4M Buy
56,156
+422
+0.8% +$12.1K ﹤0.01% 970
2024
Q1
$1.85M Buy
55,734
+5,427
+11% +$185K ﹤0.01% 877
2023
Q4
$1.79M Buy
50,307
+1,490
+3% +$47.3K ﹤0.01% 872
2023
Q3
$1.67M Buy
48,817
+7,622
+19% +$290K ﹤0.01% 867
2023
Q2
$1.65M Buy
41,195
+4,489
+12% +$178K ﹤0.01% 870
2023
Q1
$1.44M Buy
36,706
+3,848
+12% +$141K ﹤0.01% 929
2022
Q4
$1.05M Buy
32,858
+5,891
+22% +$178K ﹤0.01% 1042
2022
Q3
$765K Sell
26,967
-3,134
-10% -$107K ﹤0.01% 1178
2022
Q2
$1.08M Sell
30,101
-1,356
-4% -$54.8K ﹤0.01% 1064
2022
Q1
$1.55M Sell
31,457
-478
-1% -$25.3K ﹤0.01% 989
2021
Q4
$1.78M Buy
31,935
+99
+0.3% +$5.45K ﹤0.01% 958
2021
Q3
$1.85M Buy
31,836
+366
+1% +$22.6K ﹤0.01% 904
2021
Q2
$1.99M Buy
31,470
+1,350
+4% +$88.9K ﹤0.01% 890
2021
Q1
$1.92M Sell
30,120
-42
-0.1% -$2.44K ﹤0.01% 874
2020
Q4
$1.58M Buy
30,162
+1,947
+7% +$96K ﹤0.01% 907
2020
Q3
$1.23M Buy
28,215
+8,319
+42% +$368K ﹤0.01% 904
2020
Q2
$876K Buy
19,896
+391
+2% +$16.5K ﹤0.01% 1014
2020
Q1
$757K Buy
19,505
+1,217
+7% +$62K ﹤0.01% 1011
2019
Q4
$1.03M Buy
18,288
+133
+0.7% +$7.42K ﹤0.01% 1051
2019
Q3
$968K Buy
18,155
+1,577
+10% +$84.7K ﹤0.01% 1038
2019
Q2
$968K Sell
16,578
-504
-3% -$27.1K ﹤0.01% 1085
2019
Q1
$847K Sell
17,082
-906
-5% -$39.9K ﹤0.01% 1153
2018
Q4
$670K Sell
17,988
-996
-5% -$36.2K ﹤0.01% 1200
2018
Q3
$716K Sell
18,984
-6,860
-27% -$286K ﹤0.01% 1281
2018
Q2
$1.13M Sell
25,844
-2,438
-9% -$115K ﹤0.01% 1049
2018
Q1
$1.42M Sell
28,282
-1,982
-7% -$117K ﹤0.01% 933
2017
Q4
$1.99M Buy
30,264
+1,511
+5% +$96.1K 0.01% 793
2017
Q3
$1.72M Buy
28,753
+318
+1% +$18.9K 0.01% 841
2017
Q2
$1.84M Buy
28,435
+165
+0.6% +$10.4K 0.01% 800
2017
Q1
$1.77M Sell
28,270
-1,546
-5% -$93.1K 0.01% 823
2016
Q4
$1.72M Buy
29,816
+226
+0.8% +$13.4K 0.01% 817
2016
Q3
$1.76M Sell
29,590
-1,805
-6% -$111K 0.01% 783
2016
Q2
$1.95M Buy
31,395
+977
+3% +$60.1K 0.01% 721
2016
Q1
$1.88M Buy
30,418
+4,266
+16% +$251K 0.01% 721
2015
Q4
$1.59M Sell
26,152
-872
-3% -$51.9K 0.01% 771
2015
Q3
$1.37M Sell
27,024
-2,522
-9% -$134K 0.01% 817
2015
Q2
$1.52M Sell
29,546
-703
-2% -$36.4K 0.01% 818
2015
Q1
$1.54M Buy
30,249
+3,169
+12% +$163K 0.01% 815
2014
Q4
$1.44M Buy
27,080
+337
+1% +$17.1K 0.01% 836
2014
Q3
$1.22M Sell
26,743
-1,772
-6% -$83.4K ﹤0.01% 897
2014
Q2
$1.35M Buy
28,515
+202
+0.7% +$9.4K 0.01% 859
2014
Q1
$1.3M Sell
28,313
-201
-0.7% -$9.3K 0.01% 858
2013
Q4
$1.38M Buy
28,514
+3,377
+13% +$158K 0.01% 793
2013
Q3
$1.09M Sell
25,137
-1,227
-5% -$52.4K ﹤0.01% 865
2013
Q2
$1.08M Buy
+26,364
New +$1.1M ﹤0.01% 833

Other funds holding XRAY

US Bancorp's XRAY Position: Q1 2026 in Review

US Bancorp increased its Dentsply Sirona (XRAY) stake by 24% in Q1 2026, buying an estimated $13.5K and bringing the position to 5,587 shares worth $64.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

US Bancorp first reported a position in XRAY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.99M in Q4 2017. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • US Bancorp held 5,587 shares of Dentsply Sirona worth $64.8K as of Q1 2026.
  • US Bancorp bought 1,084 Dentsply Sirona shares in Q1 2026, an estimated $13.5K.
  • Dentsply Sirona made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #2596 holding.
  • US Bancorp first reported a position in Dentsply Sirona in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Dentsply Sirona position peaked at $1.99M in Q4 2017.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.